GeneReach Biotechnology Corp. (TPEX:4171)
21.60
+0.10 (0.47%)
Jan 22, 2026, 1:30 PM CST
GeneReach Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 104.88 | 110.27 | 216.77 | 748.61 | 663.43 | 313.68 | Upgrade |
Short-Term Investments | 135.09 | 181.01 | 285.95 | - | - | - | Upgrade |
Trading Asset Securities | 17.39 | 122.7 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 257.35 | 413.98 | 502.72 | 748.61 | 663.43 | 313.68 | Upgrade |
Cash Growth | -45.93% | -17.65% | -32.85% | 12.84% | 111.50% | 77.20% | Upgrade |
Accounts Receivable | 25.74 | 43.05 | 21.47 | 55.86 | 195.75 | 165.77 | Upgrade |
Other Receivables | 2.15 | 3.37 | 1.68 | 0.4 | 0.72 | 0.66 | Upgrade |
Receivables | 27.9 | 46.42 | 23.14 | 56.26 | 196.47 | 166.42 | Upgrade |
Inventory | 36.07 | 37.52 | 67.37 | 235.81 | 268.3 | 237.08 | Upgrade |
Prepaid Expenses | 2.59 | 3.24 | 5.88 | 8.36 | 34.68 | 31.4 | Upgrade |
Other Current Assets | 143.35 | 93.51 | 33.01 | 21.03 | 17.66 | 50.06 | Upgrade |
Total Current Assets | 467.26 | 594.67 | 632.14 | 1,070 | 1,181 | 798.64 | Upgrade |
Property, Plant & Equipment | 295.8 | 359.65 | 433.83 | 436.93 | 397.11 | 385.56 | Upgrade |
Long-Term Investments | - | - | - | - | 3.24 | 10.06 | Upgrade |
Other Intangible Assets | 14.07 | 12.4 | 12.35 | 9.49 | 10.03 | 8.84 | Upgrade |
Long-Term Deferred Tax Assets | 82.86 | 83.21 | 77.65 | 35.26 | 24 | 27.61 | Upgrade |
Other Long-Term Assets | 17.52 | 16.56 | 20.18 | 70.15 | 69.51 | 9.81 | Upgrade |
Total Assets | 877.52 | 1,066 | 1,176 | 1,622 | 1,684 | 1,241 | Upgrade |
Accounts Payable | 6.34 | 7.74 | 8.86 | 13.35 | 31.68 | 31.69 | Upgrade |
Short-Term Debt | 136 | 171 | 104 | 49 | 49 | 51 | Upgrade |
Current Portion of Long-Term Debt | - | - | 35.62 | 204.42 | 7.5 | - | Upgrade |
Current Portion of Leases | 11.06 | 11.64 | 11.38 | 12.64 | 8.54 | 7.72 | Upgrade |
Current Income Taxes Payable | - | 7 | 3.59 | 23.08 | 74.45 | 55.94 | Upgrade |
Current Unearned Revenue | 2.51 | 2.93 | 4.96 | 7.8 | 19.43 | 5.39 | Upgrade |
Other Current Liabilities | 39.21 | 39.21 | 37.5 | 74.8 | 87.62 | 93.41 | Upgrade |
Total Current Liabilities | 195.1 | 239.53 | 205.9 | 385.09 | 278.21 | 245.14 | Upgrade |
Long-Term Debt | - | - | - | 15 | 217.39 | 30 | Upgrade |
Long-Term Leases | 74.64 | 84.59 | 97.74 | 108.89 | 87.35 | 99.19 | Upgrade |
Long-Term Unearned Revenue | 9.81 | 10.57 | 8.78 | 8.95 | 8.82 | - | Upgrade |
Pension & Post-Retirement Benefits | - | - | - | - | 1.73 | 5.97 | Upgrade |
Long-Term Deferred Tax Liabilities | 6.23 | 6.29 | 1.26 | 1.28 | 1.2 | 2.39 | Upgrade |
Other Long-Term Liabilities | - | 0.02 | 0.02 | 0.02 | 1.64 | 0.06 | Upgrade |
Total Liabilities | 285.79 | 341 | 313.71 | 519.23 | 596.35 | 382.75 | Upgrade |
Common Stock | 584.58 | 574.58 | 574.58 | 459.66 | 417.87 | 405.9 | Upgrade |
Additional Paid-In Capital | 154.3 | 144.9 | 144.9 | 144.9 | 144.9 | 272.72 | Upgrade |
Retained Earnings | -120.54 | -3.29 | 114.74 | 464.44 | 491.74 | 137.95 | Upgrade |
Comprehensive Income & Other | -19.26 | 0.79 | -2.15 | -1.33 | -4.7 | -3.56 | Upgrade |
Total Common Equity | 581.77 | 716.98 | 832.06 | 1,068 | 1,050 | 813.02 | Upgrade |
Minority Interest | 9.96 | 8.51 | 30.37 | 35.01 | 38.26 | 44.74 | Upgrade |
Shareholders' Equity | 591.73 | 725.49 | 862.44 | 1,103 | 1,088 | 857.76 | Upgrade |
Total Liabilities & Equity | 877.52 | 1,066 | 1,176 | 1,622 | 1,684 | 1,241 | Upgrade |
Total Debt | 221.7 | 267.23 | 248.74 | 389.95 | 369.78 | 187.91 | Upgrade |
Net Cash (Debt) | 35.65 | 146.75 | 253.98 | 358.66 | 293.65 | 125.78 | Upgrade |
Net Cash Growth | -82.42% | -42.22% | -29.19% | 22.14% | 133.48% | 23.04% | Upgrade |
Net Cash Per Share | 0.62 | 2.55 | 4.42 | 6.05 | 5.01 | 2.19 | Upgrade |
Filing Date Shares Outstanding | 57.7 | 57.46 | 57.46 | 57.46 | 57.46 | 57.46 | Upgrade |
Total Common Shares Outstanding | 57.7 | 57.46 | 57.46 | 57.46 | 57.46 | 57.46 | Upgrade |
Working Capital | 272.16 | 355.14 | 426.24 | 684.99 | 902.32 | 553.5 | Upgrade |
Book Value Per Share | 10.08 | 12.48 | 14.48 | 18.58 | 18.27 | 14.15 | Upgrade |
Tangible Book Value | 567.7 | 704.59 | 819.72 | 1,058 | 1,040 | 804.18 | Upgrade |
Tangible Book Value Per Share | 9.84 | 12.26 | 14.27 | 18.42 | 18.10 | 14.00 | Upgrade |
Buildings | 293.81 | 293.85 | 292.04 | 267.33 | 266.03 | 263.88 | Upgrade |
Machinery | 316.86 | 332.71 | 309.58 | 273.19 | 231.16 | 171.49 | Upgrade |
Construction In Progress | 0.08 | - | - | 20.95 | - | 0.04 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.